Loomis, Sayles & Company

Loomis, Sayles & Company’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Loomis, Sayles & Company’s Portfolio INBX Stock Details INBX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$41.1M	Sell
2023 Q3	$20.5M	Sell
2023 Q2	$29.9M	Sell
2023 Q1	$21.9M	Buy
2022 Q4	$24.7M	Sell
2022 Q3	$18.4M	Sell
2022 Q2	$11.8M	Sell
2022 Q1	$23.2M	Buy